Table 1 Characteristics of lymphoma patient samples
Patient# | AGE | SEX | RACE | TYPE OF LYMPHOMA | CYTOGENETICS/KARYOTYPE | p53 status Exons 5-9 (cDNA) |
|---|---|---|---|---|---|---|
1 | 62 | M | Caucasian | MZL | Normal/46,XY [23] | wt |
2 | 76 | M | Caucasian | SLL/CLL | 84.5%-trisomy 12 | wt |
15.5%- deletion of 17p | ||||||
11%-loss of lgH locus | ||||||
3 | 86 | M | Caucasian | MZL | Normal/46, XY [23] | wt |
4 | 71 | F | Caucasian | SLL/CLL | 67.5%-trisomy 12 | wt |
5 | 64 | F | African-American | SLL/CLL | 86.5%-deleted 13q | wt |
6 | 72 | M | Caucasian | MZL | 45%-t(2;7)(p12;q21-22) | wt |
7 | 64 | F | Caucasian | SLL/CLL | 54.5%- deleted 13q | wt |
8 | 81 | F | Caucasian | SLL/CLL | 58.5%- deleted 13q | wt |
9 | 69 | F | Caucasian | SLL/CLL | 51%- deleted 13q | mt |
9%- deleted 17p | (Lys132Arg) | |||||
10 | 62 | M | Caucasian | SLL/CLL | 23.5%- deleted 13q | wt |
26%-31gH copies | ||||||
11 | 69 | F | Caucasian | SLL/CLL | 72%- deleted 13q | wt |